For the quarter ending 2026-03-31, SILO has $7,018,132 in assets. $1,336,296 in debts. $3,902,514 in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|
| Cash and cash equivalents | 3,902,514 | 3,917,627 | 4,333,672 | |
| Short-term investments, at fair value | 2,129,659 | 1,948,579 | 1,926,297 | |
| Crypto assets, at fair value | 173,462 | 72,283 | - | |
| Crypto assets, at cost | 68,673 | - | - | |
| Prepaid expenses and other current assets | 529,386 | 225,880 | 113,062 | |
| Total current assets | 6,803,694 | 6,164,369 | 6,373,031 | |
| Intangible assets, net | 214,438 | 220,312 | 223,250 | |
| Prepaid expenses and other assets - non-current | - | - | 56,226 | |
| Total long-term assets | 214,438 | 220,312 | 279,476 | |
| Total assets | 7,018,132 | 6,384,681 | 6,652,507 | |
| Accounts payable and accrued expenses | 632,743 | 636,237 | 977,795 | |
| Deferred revenue - current portion | 72,102 | 72,102 | 72,102 | |
| Total current liabilities | 704,845 | 708,339 | 1,049,897 | |
| Deferred revenue - long-term portion | 631,451 | 667,502 | 685,527 | |
| Total long-term liabilities | 631,451 | 667,502 | 685,527 | |
| Total liabilities | 1,336,296 | 1,375,841 | 1,735,424 | |
| Common stock, 0.0001 par value, 100,000,000 shares authorized 16,266,593 and 13,318,273 shares issued and outstanding at march 31, 2026 and december 31, 2025, respectively | 1,627 | 1,046 | 865 | |
| Additional paid-in capital | 26,810,994 | 23,607,308 | 22,407,075 | |
| Accumulated other comprehensive income | 8,721 | 11,345 | 9,564 | |
| Accumulated deficit | -21,139,506 | -18,610,859 | -17,500,421 | |
| Total stockholders equity | 5,681,836 | 5,008,840 | 4,917,083 | |
| Total liabilities and stockholders equity | 7,018,132 | 6,384,681 | 6,652,507 | |
Silo Pharma, Inc. (SILO)
Silo Pharma, Inc. (SILO)